Subscribe to RSS
Download PDF
DOI: 10.1055/s-0043-1761166
Imaging Recommendations for Molecular Imaging
Abstract
In vivo molecular imaging is having a great potential that will have an impact on the medicine by detecting diseases in early stages like screening, identifying extent of disease, selecting disease- and patient-specific therapeutic treatment which will be the hallmark of the personalized medicine, for directed targeted therapy, and also for measuring molecular-specific effects of treatment. Currently, most commonly used molecular modalities are positron emission tomography- or single-photon emission computed tomography-based techniques.
Publication History
Article published online:
12 May 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Mankoff DA. A definition of molecular imaging. J Nucl Med 2007; 48 (06) 18N-21N [PubMed] [Google Scholar]
- 2 Peterson TE, Manning HC. Molecular imaging: 18F-FDG PET and a whole lot more. J Nucl Med Technol 2009; 37 (03) 151-161 [PMC free article] [PubMed] [Google Scholar]
- 3 Wong ST. Emerging treatment combinations: integrating therapy into clinical practice. Am J Health Syst Pharm 2009;66(23, Suppl 6):S9–S14 [PubMe d] [Google Scholar]
- 4 Blanco E, Kessinger CW, Sumer BD, Gao J. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med (Maywood) 2009; 234 (02) 123-131 [PMC free article] [PubMed] [Google Scholar]
- 5 Desar IM, van Herpen CM, van Laarhoven HW, Barentsz JO, Oyen WJ, van der Graaf WT. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. Cancer Treat Rev 2009; 35 (04) 309-321 [PubMed] [Google Scholar]